Read before buying drugs   
RXMedsDoctor.net

Select Drugs:
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z

Videx

Form.

Tablets: 25 milligrams,
Tablets: 50 milligrams,
Tablets: 100 milligrams,
Tablets: 150 milligrams,
Tablets: 200 milligrams.
Oral solution: 100 milligrams,
Oral solution: 167 milligrams,
Oral solution: 250 milligrams.
Capsules: 125 milligrams,
Capsules: 200 milligrams,
Capsules: 250 milligrams,
Capsules: 400 milligrams.

No Prescription

Videx is prescribed for the treatment of HIV infection in adults and children.
Videx is one of the drugs prescribed to fight the human immunodeficiency virus (HIV)--the deadly cause of AIDS. Over a period of years, HIV slowly destroys the immune system, leaving the body defenseless against infection. Videx disrupts reproduction of HIV, thereby staving off the immune system's collapse.

Signs and symptoms of advanced HIV infection include diarrhea, fever, headache, infections, problems with the nervous system, rash, sore throat, and significant weight loss.

Dosage.

Adults weighing 60 kg or more should receive 200 milligrams twice daily of the tablets or 250 milligrams twice daily of the powder. Adults weighing less than 60 kg require 125 milligrams twice daily of the tablets or 167 milligrams twice daily of the powder.

Videx is broken down by stomach acid. To prevent breakdown, each formulation contains a buffer (antacid). In order to achieve adequate buffering each adult or pediatric dose should contain two tablets of Videx. Children less than one year of age can achieve adequate buffering with one tablet.

Pediatric doses are based on body surface area according to the following schedule. If body surface area is 1.1-1.4 m2, 100 milligrams as tablets twice daily or 12.5 milliliters twice daily of the pediatric solution should be administered. Children with a body surface area 0.8-1 m2 should receive 75 milligrams of the tablets twice daily or 9.5 milliliters twice daily of the pediatric solution. A body surface area of 0.5-0.7 m2 corresponds to 50 milligrams as tablets twice daily or 6 milliliters of the pediatric solution twice daily. If the body surface area is less than 0.4 m2, the recommended dose is 25 milligrams as tablets twice daily or 3 milliliters of the pediatric solution twice daily.

Videx should be administered on an empty stomach because food reduces the absorption of Videx by as much as 50%.
Videx ED is a long-acting formulation of Videx. Adults should receive 250-400 milligrams once daily on an empty stomach. Capsule should be swallowed intact.
Videx EC causes less stomach irritation than regular Videx (Videx).

If you have a kidney or liver problem, your dosage may be reduced.

ADULTS

Tablets

For adults weighing 132 pounds or more, the recommended dose is 200 mg every 12 hours. Those weighing less than 132 pounds usually take 125 mg every 12 hours.

Buffered Powder for Oral Solution

For adults weighing 132 pounds or more, the recommended dose is 250 mg every 12 hours. Those weighing less than 132 pounds usually take 167 mg every 12 hours.

Videx EC Delayed-Release Capsules

For adults weighing 132 pounds or more, the recommended dose is 400 mg once a day. If you weigh less than 132 pounds, the usual dose is 250 mg once a day.

CHILDREN

The recommended dose for pediatric patients 2 weeks of age and older varies according to the child's weight. Videx EC capsules are not prescribed for children.

Side Effects.

The most severe side effects are inflammation of the pancreas (pancreatitis), liver failure and nerve damage in the arms and legs (peripheral neuropathy).

Symptoms of peripheral neuropathy are:
- Numbness;
- Pain in the feet or hands;
- Tingling;

Other side effects include:
- Chills;
- Diarrhea;
- Fever;
- Headache;
- Nausea;
- Rash;
- Stomach pain;
- Vomiting;

Videx side effects that you should report to your health care professional or doctor as soon as possible:
- Weakness;
- Vomiting;
- Tingling;
- Rash;
- Pain;
- Pain In The Feet And Hands;
- Numbness;
- Nausea;
- Itching;
- Headache;
- Fever;
- Diarrhea;
- Chills;
- Burning;
- Abdominal Pain;
(c) 2017